Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.46 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30783463 | 0.95 | PTPN1 (0.43) | PTPN1GRB2TLR2TLR1KMT2A | |
| SCHEMBL30783464 | 0.95 | PTPN1 (0.43) | PTPN1GRB2TLR2TLR1KMT2A | |
| SCHEMBL31298682 | 0.92 | PTPN1 (0.41) | PTPN1GRB2TLR2TLR1KMT2A | |
| SCHEMBL32670193 | 0.91 | PTPN1 (0.41) | PTPN1GRB2TLR2TLR1PAX8 | |
| SCHEMBL15964057 | 0.89 | ALB (0.46) | PTPN1TLR2TLR1KMT2ACXCR3 | |
| SCHEMBL1755616 | 0.86 | PAX8 (0.55) | TLR2TLR1KMT2APAX8TDP1 | |
| SCHEMBL12214994 | 0.84 | MMP1 (0.49) | TLR2TLR1KMT2APAX8TDP1 | |
| SCHEMBL30783506 | 0.84 | KMT2A (0.49) | TLR2TLR1KMT2APAX8TDP1 | |
| SCHEMBL30783473 | 0.84 | KMT2A (0.49) | TLR2TLR1KMT2APAX8TDP1 | |
| SCHEMBL30783454 | 0.84 | KMT2A (0.49) | TLR2TLR1KMT2APAX8TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025029608-A1 | FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF | RATIO THERAPEUTICS, INC. (US) | 2025-02-06 | — | — | WO | disclosed |